A Distinguished Leader in the Bleeding Disorders Community

The resources in this edition includes articles, videos, and additional background information relevant to the ever-evolving technologies that are driving exciting advances in bleeding disorders treatment and care.

ITP is a rare autoimmune disorder that causes a significant reduction in platelets, which are necessary for clotting.

VGA039 is a subcutaneously-delivered monoclonal antibody therapy designed to target Protein S as a means of restoring proper blood clotting in people with all types of von Willebrand disease.

Female hemophilia carriers often go undiagnosed. Learn about the importance of identifying and supporting these individuals to ensure equitable access to care.